Developmental and Epileptic Encephalopathy: Pathogenesis of Intellectual Disability Beyond Channelopathies

Alexandra D Medyanik1, Polina E Anisimova1, Angelina O Kustova1

  • 1Institute of Neuroscience, Lobachevsky State University of Nizhny Novgorod, 23 Gagarin Ave., 603022 Nizhny Novgorod, Russia.

Biomolecules
|January 25, 2025
PubMed

Insights

Developmental and epileptic encephalopathies (DEEs) involve epilepsy and developmental delay, often due to genetic factors. This review focuses on non-channelopathy mechanisms causing intellectual disability in DEE patients.

Area of Science:

  • Neurology
  • Genetics
  • Developmental Biology

Background:

  • Developmental and epileptic encephalopathies (DEEs) are severe neuropediatric disorders characterized by epilepsy, psychomotor delay, and cognitive deficits.
  • Genetic factors are implicated in 30-50% of DEE cases, with mutations often affecting ion channels (channelopathies).
  • However, non-channelopathy mechanisms, including impaired neurogenesis and synaptopathies, also contribute significantly to DEE pathogenesis.

Purpose of the Study:

  • To review recent literature on non-channelopathy mechanisms in DEEs.
  • To emphasize the link between epileptiform activity and intellectual disability in DEE.
  • To highlight recently identified genes involved in DEE pathogenesis.

Main Methods:

  • Literature review of recent publications on DEEs.
  • Focus on non-channelopathy mechanisms and their link to intellectual disability.
  • Analysis of genetic factors and their role in DEE pathogenesis.

Main Results:

  • Channelopathies are a significant cause of DEEs, but non-channelopathy mechanisms are increasingly recognized.
  • Identified mechanisms include impaired neurogenesis, metabolic disorders, and synaptopathies.
  • Several novel genes associated with DEE pathogenesis have been recently identified.

Conclusions:

  • Non-channelopathy mechanisms play a crucial role in the pathogenesis of DEEs, contributing to intellectual disability.
  • Understanding these diverse mechanisms is vital for improved diagnosis and therapeutic strategies for DEE.
  • Further research into newly identified genes will advance our comprehension of DEE and inform treatment development.

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
Intellectual Disability01:29

Intellectual Disability

Intellectual disability (ID) is a neurodevelopmental condition characterized by deficits in intellectual and adaptive functioning that manifest during the developmental period. This condition encompasses challenges in reasoning, memory, problem-solving, and learning, accompanied by impairments in everyday life skills, such as communication, self-care, and social interactions. Intellectual disability affects approximately 1% of the population in the United States, impacting an estimated 5...
Encephalitis l: Introduction01:19

Encephalitis l: Introduction

Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
Hepatic Encephalopathy01:29

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...